Corrigendum: Targeting Endolysosomal Two-Pore Channels to Treat Cardiovascular Disorders in the Novel COronaVIrus Disease 2019

Front Physiol. 2021 May 28:12:690189. doi: 10.3389/fphys.2021.690189. eCollection 2021.

¹ Laboratory of General Physiology, Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, Pavia, Italy.
² Department of Medicine and Health Sciences "V. Tiberio", University of Molise, Campobasso, Italy.
³ Section of Human Anatomy, Department of Mental and Physical Health and Preventive Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
⁴ Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
⁵ School of Medicine, Department of Biomedicine, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico.

Abstract

[This corrects the article DOI: 10.3389/fphys.2021.629119.].

Keywords: COVID-19; NAADP; PI(3,5)P2; SARS-CoV-2; cardiovascular system; endolysosomal Ca2+ signaling; two-pore channels.